+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Docetaxel"

Head and Neck Cancer Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Head and Neck Cancer Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
PSMA - Targeted Therapy Pipeline Review - Product Thumbnail Image

PSMA - Targeted Therapy Pipeline Review

  • Report
  • September 2025
  • Global
From
Brazil Cancer Drugs Clinical Trials Insight 2024 - Product Thumbnail Image

Brazil Cancer Drugs Clinical Trials Insight 2024

  • Report
  • August 2024
  • 660 Pages
  • Brazil
From
From
From
Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

  • Clinical Trials
  • February 2018
  • 225 Pages
  • Global
From
Head and Neck Cancer Therapeutics: Global Markets - Product Thumbnail Image

Head and Neck Cancer Therapeutics: Global Markets

  • Report
  • August 2022
  • 148 Pages
  • Global
From
From
From
From
From
Bispecific antibody - Competitive landscape, 2023 - Product Thumbnail Image

Bispecific antibody - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Checkpoint Inhibitors - Competitive landscape, 2023 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive landscape, 2023

  • Report
  • April 2023
  • 350 Pages
  • Global
From
From
Loading Indicator

Docetaxel is a chemotherapy drug used in the treatment of various types of cancer, including breast, ovarian, and non-small cell lung cancer. It is a semi-synthetic derivative of a natural substance found in the bark of the European yew tree. Docetaxel works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is usually administered intravenously, and is often used in combination with other drugs. Docetaxel is a widely used oncology drug, and is often prescribed as a first-line treatment for certain types of cancer. It is also used in the treatment of advanced or metastatic cancer, and is sometimes used in combination with other drugs to improve the effectiveness of treatment. Some companies in the Docetaxel market include Bristol-Myers Squibb, Pfizer, and Sanofi. Show Less Read more